NL-OMON46982已完成2 期
The efficacy and safety of Irreversible Electroporation for the ablation of Small Renal Masses: A prospective in-vivo pilot study - Efficacy and Safety of IRE for SRMs.
Academisch Medisch Centrum (AMC)0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- Age * 18 years
- •- Solid, enhancing mass on cross sectional imaging
- •- Signed informed consent
- •- Candidate for focal ablative therapy
排除标准
- •- Irreversible bleeding disorders
- •- Anaesthesia Surgical Assignment (ASA), category * IV
- •- ICD / pacemaker
- •- Severe cardiovascular disease in medical history
研究者
相似试验
撤回
2 期
The Efficacy and Safety of Irreversible Electroporation for the Ablation of Renal Masses: A Prospective, Human, In-Vivo Study.renal cell carcinomarenal cancer10038364NL-OMON40514Academisch Medisch Centrum10
已完成
2 期
The Safety and Efficacy of Irreversible Electroporation for the Ablation of Prostate Cancer Assessed by Procedural Related Side Effects and Post Prostatectomy Histology: A Prospective Human In-Vivo StudyProstatic neoplasm10038597Prostate cancerNL-OMON39362Academisch Medisch Centrum10
Unknown
1 期
Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and PancreasRefractory NeoplasmsNCT02822066First Affiliated Hospital of Zhejiang University60
Unknown
1 期
Efficacy and Safety of IRE for RMsKidney CancerNCT02298608Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)10
招募中
不适用
Efficacy of IRE for patients with HCCHepatocellular carcinomaJPRN-jRCTs032190083Sugimoto Katsutoshi45